SEC Form 4 · accession 0001140361-15-045407
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Wachter Ph.D.
Officer — Chief Technology Officer
Period of report
Dec 21, 2015
Accepted (ET)
Dec 22, 2015 · 8:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2015 | M | 120,000 | $1.02 | A | 5,513,236 | D | |
| Common Stock | holding | — | — | — | 824,248 | I | 401(k) Plan | |
| Common Stock | holding | — | — | — | 4,867 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.02 | Dec 21, 2015 | M | 120,000 | D | Jun 23, 2006 | Jun 23, 2016 | Common Stock | 120,000 | 120,000 | D |